Diphtheria Tetanus Pertussis Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine Adsorbed
Diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b conjugate vaccine (adsorbed)
Product Details
WHO Product ID
FVP-P-225
Status
Prequalified
Date of prequalification
Vaccine type
Diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b conjugate vaccine (adsorbed)
Abbreviated Name
DTwP-HepB-Hib
Commercial Name
Diphtheria Tetanus Pertussis Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine Adsorbed
PQ Holder
India
NRA of record
Central Drugs Standard Control Organization
Product description
Pharmaceutical Form
Liquid: Ready to use
Presentation
Vial
Number of doses
10
Route of administration
Intramuscular
Vaccine Vial Monitor
Type 14
Shelf-life
30 months
Storage temperature
2 - 8°C
Diluent
N/A
Preservative
Thiomersal
Preservative concentration
0.01%
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be used in subsequent immunization sessions (up to 28 days) if the conditions outlined in the WHO Policy Statement are met.
Product Packaging
Secondary Container
Tertiary Container
Component Packed
Active (Vaccine)
Total doses
50
Description
Carton of 50 vials (500 doses) [Dimensions: 18.5x9.5x6 cm]
Dimensions
18.5 x 9.5 x 6.0 cm
Cold Chain Volume (cm³/dose)
2.11
